U.S. federal trademark · Serial No. 90271366
medical treatment, namely, administering gene therapies in the nature of in vivo and ex vivo vector treatments; medical treatment, namely, administering gene therapies in the nature of lentiviral vector therapies; medical treatment, namely, administering gene therapies in the nature of gene therapies for the treatment of rare diseases; medical treatment, namely, administering gene therapies in the nature of gene therapies for Hereditary Tyrosinemia Type 1; medical treatment, namely, administering gene therapies in the nature of gene therapies for orphan disease; medical treatment, namely, administering gene therapies in the nature of gene therapies for inborn errors of hepatic metabolism
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.